Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Cardiotoxicity × Trastuzumab × Clear all

Status

Sponsor Class

OTHER 5 NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Stomach Neoplasms 2 Inflammatory Breast Neoplasms 2 Rectal Neoplasms 1 Neoplastic Cells, Circulating 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Invasive Breast Cancer 1 HER2 Positive Breast Cancer 1 Elderly Metastatic Breast Cancer Population 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiotoxicity 1 Breast Neoplasms, Male 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Cancer 1

Interventions

Razoxane 4 Doxorubicin 4 Dexrazoxane 4 Vincristine 3 Etoposide 3 Radiotherapy 2 Prednisone 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Bleomycin 2 hydrocortisone hemisuccinate 1 Watchful Waiting 1 Trastuzumab 1 Proton Therapy 1 Observation 1 Mercaptopurine 1 Leucovorin 1 Ifosfamide 1 Hydrocortisone 1 Enalapril 1 Cytarabine 1 Cyclophosphamide 1 Cisplatin 1 Carvedilol 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00968682 2014-12-31

CADY Study ICORG 08-01

Cancer Trials Ireland

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡